TY 2012 Form 990

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)
(1) Ralph Yates DO........................................................................ Chair of the Board	3.00 .......................	X	X	0	0
(2) Karen Talmadge PhD........................................................................ Vice Chair of the Board	6.00 .......................2.20	X	X	0	0
(3) Pearson C Cummin III MBA........................................................................ Secretary - Treasurer	3.00 .......................6.20	X	X	0	0
(4) Larry Hausner MBA........................................................................ Chief Executive Officer	2.00 .......................35.50	X	X	575,132	260,241
(5) Alvin C Powers MD........................................................................ Board of Directors	2.00 .......................	X		0	0
(6) David K Bloomgarden MD FACE........................................................................ Board of Directors	2.00 .......................3.00	X		0	0
(7) John Fitzgerald III........................................................................ Board of Directors	1.00 .......................	X		0	0
(8) S Daniel Johnson........................................................................ Board of Directors	3.00 .......................	X		0	0
(9) Orville G Kolterman MD........................................................................ Board of Directors	2.00 .......................	X		0	0
(10) Peter K Kompaniez JD........................................................................ Board of Directors	1.00 .......................	X		0	0
(11) Karmeen Kulkarni MS RD BC-ADM CDE........................................................................ Board of Directors	2.00 .......................	X		0	0
(12) Kenneth Moritsugu MD MPH FACPM........................................................................ Board of Directors	2.00 .......................	X		0	0
(13) James W Quinn........................................................................ Board of Directors	1.00 .......................	X		0	0
(14) Robert Sevier MD........................................................................ Board of Directors	3.00 .......................	X		0	0
(15) Donald J Wagner........................................................................ Board of Directors	3.00 .......................	X		0	0
(16) Ann Juster MSW........................................................................ Board of Directors	2.00 .......................	X		0	0
(17) John W Griffin Jr........................................................................ Board of Directors	2.00 .......................1.00	X		0	0

Part X Balance Sheet Check if Schedule O contains a response to any question in this Part X ...............
	1	Cashnon-interest-bearing .............		1
2	Savings and temporary cash investments .........	1,260,171	2	729,908
3	Pledges and grants receivable, net ...........	12,682,749	3	34,340,604
4	Accounts receivable, net .............		4
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
			5
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
			6
7	Notes and loans receivable, net .............		7
8	Inventories for sale or use ..............		8
9	Prepaid expenses and deferred charges ..........		9
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a
b	Less: accumulated depreciation .....	10b			10c
11	Investments—publicly traded securities ..........		11
12	Investments—other securities. See Part IV, line 11 .....	82,008	12	84,176
13	Investments—program-related. See Part IV, line 11 .....		13
14	Intangible assets ...............		14
15	Other assets. See Part IV, line 11 ...........		15
16	Total assets. Add lines 1 through 15 (must equal line 34)......	14,024,928	16	35,154,688
	17	Accounts payable and accrued expenses .........		17
18	Grants payable .................	8,975,876	18	10,265,209
19	Deferred revenue ................		19
20	Tax-exempt bond liabilities .............		20
21	Escrow or custodial account liability. Complete Part IV of Schedule D..		21
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........		22
23	Secured mortgages and notes payable to unrelated third parties ..		23
24	Unsecured notes and loans payable to unrelated third parties ....		24
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................		25
26	Total liabilities. Add lines 17 through 25.........	8,975,876	26	10,265,209
		Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............		27
28	Temporarily restricted net assets ...........	4,967,044	28	24,805,303
29	Permanently restricted net assets ...........	82,008	29	84,176
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........		30
31	Paid-in or capital surplus, or land, building or equipment fund .....		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	5,049,052	33	24,889,479
34	Total liabilities and net assets/fund balances ........	14,024,928	34	35,154,688

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E.)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in

section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross

receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of

its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses

acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box that describes the type of supporting organization and complete lines 11e through 11h.

Type I

Type II

Type III - Functionally integrated

Type III - Non-functionally integrated

By checking this box, I certify that the organization is not controlled directly or indirectly by one or more disqualified persons other than foundation managers and other than one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2).

If the organization received a written determination from the IRS that it is a Type I, Type II, or Type III supporting organization, check this box ..................................................

Since August 17, 2006, has the organization accepted any gift or contribution from any of the
following persons?

(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)

Yes

and (iii) below, the governing body of the supported organization? ................

11g(i)

(ii) A family member of a person described in (i) above? ......................

11g(ii)

(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................

11g(iii)

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization in col. (i) listed in your governing document?		(v) Did you notify the organization in col. (i) of your support?		(vi) Is the organization in col. (i) organized in the U.S.?		(vii) Amount of monetary support
(i) Name of supported organization	(ii) EIN	Yes	No	Yes	No	Yes	No	(vii) Amount of monetary support


Total

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2012

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") ....	45,771,623	35,815,958	36,423,872	34,135,315	55,590,601	207,737,369
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......
3	The value of services or facilities furnished by a governmental unit to the organization without charge..
4	Total. Add lines 1 through 3	45,771,623	35,815,958	36,423,872	34,135,315	55,590,601	207,737,369
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						8,799,847
6	Public support. Subtract line 5 from line 4.						198,937,522

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
7	Amounts from line 4..	45,771,623	35,815,958	36,423,872	34,135,315	55,590,601	207,737,369
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...		193	1,979	1,753	3,388	7,313
9	Net income from unrelated business activities, whether or not the business is regularly carried on..
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..
11	Total support (Add lines 7 through 10).						207,744,682

Gross receipts from related activities, etc. (see instructions) ..................

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 6, column (f) divided by line 11, column (f)) .........

95.760 %

Public support percentage for 2011 Schedule A, Part II, line 14 ...............

100.000 %

16a

33 1/3% support test—2012. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2011. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2012. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2011. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......
3	Gross receipts from activities that are not an unrelated trade or business under section 513..
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge..
6	Total. Add lines 1 through 5.
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons...
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2008	(b) 2009	(c) 2010	(d) 2011	(e) 2012	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2012 (line 8, column (f) divided by line 13, column (f)) .........

0 %

Public support percentage from 2011 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2012 (line 10c, column (f) divided by line 13, column (f)) ......

0 %

Investment income percentage from 2011 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests—2012. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ........ right arrow

33 1/3% support tests—2011. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions ..... right arrow

Schedule A (Form 990 or 990-EZ) 2012

Page 4

Part IV

Supplemental Information. Complete this part to provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Explanation

Schedule A (Form 990 or 990-EZ) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

OMB No. 1545-0047

2012

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, $5,000 or more (in money or
property) from any one contributor. Complete Parts I and II.

Special Rules

For a section 501(c)(3) organization filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi) and received from any one contributor, during the year, a contribution of the
greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 for use exclusively for religious, charitable,
scientific, literary, or educational purposes, or the prevention of cruelty to children or animals. Complete Parts I, II, and
III.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions for use exclusively for religious, charitable, etc., purposes, but these contributions did
not total to more than $1,000. If this box is checked, enter here the total contributions that were received during
the year for an exclusively religious, charitable, etc., purpose. Do not complete any of the parts unless the General Rule
applies to this organization because it received nonexclusively religious, charitable, etc., contributions of $5,000 or more
during the year ......................... Arrow Bullet

Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2 of its Form 990; or check the box on line H of its
Form 990-EZ or on Part I, line 2 of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 2

Name of organization American Diabetes Association Research Foundation Inc

Part I	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	RESTRICTED RESTRICTED RESTRICTED RESTRICTED, RESTRICTED RESTRICTED	$RESTRICTED	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II if there is a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 3

Name of organization American Diabetes Association Research Foundation Inc

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Page 4

Name of organization
American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part III

Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet

$
Use duplicate copies of Part III if additional space is needed.

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2012)

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet

Attach to Form 990. SchDMd Bullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate contributions to (during year) ...
3	Aggregate grants from (during year) .....
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements .......................	2a
b	Total acreage restricted by conservation easements ..................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ....................	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenues included in Form 990, Part VIII, line 1 ........................ SchDMd Bullet

(ii)

Assets included in Form 990, Part X .............................. SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenues included in Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2012

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No

If "Yes," explain the arrangement in Part XIII and complete the following table:


c	Beginning balance .................................	1c
d	Additions during the year ..............................	1d
e	Distributions during the year .............................	1e
f	Ending balance ...................................	1f

Did the organization include an amount on Form 990, Part X, line 21? .....................

Yes No

If “Yes,” explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........

Part V

Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	b (c)Two years back	(d)Three years back	(e)Four years back
1a	Beginning of year balance ....
b	Contributions ........
c	Net investment earnings, gains, and losses
d	Grants or scholarships .....
e	Other expenditures for facilities and programs ........
f	Administrative expenses ....
g	End of year balance ......

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

Permanent endowment SchDMd Bullet

Temporarily restricted endowment SchDMd Bullet

The percentages in lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations ........................

3a(i)

(ii) related organizations ........................

3a(ii)

If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment. See Form 990, Part X, line 10.

Description of property		(a) Cost or other basis (investment)	(b)Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value
1a	Land .................
b	Buildings ................
c	Leasehold improvements ............
d	Equipment ................
e	Other .................
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......

Schedule D (Form 990) 2012

Page 3

Part VII

InvestmentsOther Securities. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)		(b)Book value	(c) Method of valuation: Cost or end-of-year market value
(1)Financial derivatives
(2)Closely-held equity interests
(3)Other (A) Financial derivatives and other financial products
(B) Closely-held equity interests







Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. See Form 990, Part X, line 13.

(a) Description of investment type		(b) Book value	(c) Method of valuation: Cost or end-of-year market value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. See Form 990, Part X, line 15.

(a) Description				(b) Book value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities. See Form 990, Part X, line 25.

1.(a) Description of liability		(b) Book value
Federal income taxes
Federal income taxes








Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)
2. Fin 48 (ASC 740) Footnote. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII .....................................................

Schedule D (Form 990) 2012

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1	Total revenue, gains, and other support per audited financial statements .......			1	56,291,250
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains on investments ..........	2a	2,168
b	Donated services and use of facilities .........	2b	695,093
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................			2e	697,261
3	Subtract line 2e from line 1.....................			3	55,593,989
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b.......................			4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......			5	55,593,989

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1	Total expenses and losses per audited financial statements ...........			1	36,450,823
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities ..........	2a	695,093
b	Prior year adjustments ..............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d	-1,006,675
e	Add lines 2a through 2d......................			2e	-311,582
3	Subtract line 2e from line 1.....................			3	36,762,405
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.......................			4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......			5	36,762,405

Part XIII

Supplemental Information

Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Identifier	Return Reference	Explanation
X	2	The following was disclosed related to uncertain tax positions in the audited financial statements The American Diabetes Association and the American Diabetes Association Research Foundation, Inc. are exempt from income taxes under Section 501c3 of the Internal Revenue Code the Code and charitable contributions to these organizations qualify for tax deductions as described in the Code. The American Diabetes Association Property Title Holding Company, Inc. is exempt from income taxes under Section 501c2 of the Code. These entities have been classified as organizations that are not private foundations under Section 509a of the Code. The Association recognizes the effect of income tax positions only if those positions more likely than not would be sustained upon examination by the Internal Revenue Service. The Association has analyzed the tax positions taken and has concluded that as of December 31, 2012, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or asset or disclosure in the financial statements.
XII	2d	Prior Year Research Grants Awards Refunds/Forfeitures 1,006,675.

Schedule D (Form 990) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization
American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

General Information on Activities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 14b.

For grantmakers. Does the organization maintain records to substantiate the amount of the grants or

assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used to award

the grants or assistance? ...................................

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of grant funds outside
the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	Canada	Program Services	Research grants	48,500
















3a	Sub-total .....			48,500
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)			48,500

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2012

Schedule F (Form 990) 2012

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered “Yes” to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement
Canada	Diabetes Research Grant Support	48,500	Check

Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .... MediumBullet

Enter total number of other organizations or entities ....................... MediumBullet

Schedule F (Form 990) 2012

Schedule F (Form 990) 2012Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2012

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2012

Page 5

Part V

Supplemental Information
Complete this part to provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

Identifier	ReturnReference	Explanation
I	1	Grant awarded to the Canadian Diabetes Association for a joint ADA-CDA postdoctoral fellowship pilot program. The program is designed to encourage international training of diabetes researchers. The program provides training grants for U.S. post-doctoral fellows in diabetes research performing their work in Canada, as well as Canadian fellows carrying out their fellowship work in the U.S. Also, it encourages international scientific discourse. In 2012, two institutions were awarded the ADA-CDA postdoctoral fellowship grant, Columbia University 25,500 and Dana-Faber Cancer Institute 23,000. The American Diabetes Association Research Foundation closely monitors the use of grant funds. Each grantee is required to submit a detailed Annual Progress Report, which includes a scientific and financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the Annual Progress Report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. After the completion of the final year of the grant, a Cumulative Final Report is required within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future American Diabetes Association Research Foundation awards until the obligations for the award are complete.

Schedule F (Form 990) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization
American Diabetes Association Research Foundation Inc

Employer identification number
54-1734511

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC Code section if applicable	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	150,000	ADA Ethicon Covidien - Basic
(2) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501 c3	199,853	ADA Ethicon Covidien - Clinical
(3) Massachusseets General Hospital 50 Staniford Street 10th Floor Boston,MA02214	04-2697983	501 c3	17,483	ADA-Medtronic Technology in Diabetes Fellowship
(4) Albert Einstein College of Medicine 1300 Morris Park Ave Bronx,NY10461	13-1624225	501 c3	65,806	ADA-Merck Clinical/Translational Postdoctoral Fellowship
(5) Massachusetts General Hospital 50 Staniford Street 10th Floor Boston,MA02214	04-2697983	501 c3	75,000	ADA-Merck Clinical/Translational Postdoctoral Fellowship
(6) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48109	38-6006309	501 c3	140,481	ADA-Merck Clinical/Translational Postdoctoral Fellowship
(7) Emory University School of Medicine 1599 Clifton Road NE 4th Floor MAIL Atlanta,GA30322	58-0566256	501 c3	199,580	ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(8) Massachusseets General Hospital 50 Staniford Street 10th Floor Boston,MA02214	04-2697983	501 c3	177,056	ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(9) Stanford University School of Medicine 300 Pasteur Drive Stanford,CA94305	94-1156365	501 c3	200,000	ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(10) University of California San Francisco 1855 Folsom St Suite 425 San Francisco,CA94143	94-6036493	501 c3	150,000	ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(11) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	45,000	ADA-Takeda Pharmaceuticals Beta Cell Award
(12) University of Southern California 1540 Alcazar Street CHP 100 Los Angeles,CA90033	95-1642394	501 c3	22,500	ADA-APMA Fellowship Award
(13) Albany Medical College 47 New Scotland Avenue Mc-116 Albany,NY12208	14-1338310	501 c3	109,250	Basic Science
(14) Albert Einstein College of Medicine 1300 Morris Park Ave Bronx,NY10461	13-1624225	501 c3	327,750	Basic Science
(15) Baylor College of Medicine One Baylor Plaza Houston,TX77030	74-1613878	501 c3	327,750	Basic Science
(16) Beckman Research Institute of the City of Hope 1450 East Duarte Road Duarte,CA91010	95-3432210	501 c3	109,250	Basic Science
(17) Beth Israel Deaconess Medical Center 330 Brookline Ave E BR-259 Boston,MA02219	04-2103881	501 c3	327,750	Basic Science
(18) Boston University School of Medicine 715 Albany Street M-921 Boston,MA02118	04-2103547	501 c3	289,205	Basic Science
(19) Burke Medical Research Institute 785 Mamaroneck Avenue White Plains,NY10605	13-3434924	501 c3	108,813	Basic Science
(20) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501 c3	109,250	Basic Science
(21) Children's Hospital of New Orleans 200 Henry Clay Avenue New Orleans,LA70118	72-0467503	501 c3	103,500	Basic Science
(22) College of Staten Island City University of New York 2800 Victory Boulevard Rm 1C-202 Staten Island,NY10314	13-2933777	501 c3	91,333	Basic Science
(23) Colorado State University 408 University Services Center Fort Collins,CO80523	84-6000545	115	109,110	Basic Science
(24) Columbia University POBox 29789 New York,NY10987	13-5598093	501 c3	109,250	Basic Science
(25) Drexel University College of Medicine 2900 W Queen Ln Philadelphia,PA19129	23-2979433	501 c3	109,249	Basic Science
(26) Georgia Health Sciences University 1120 15th Street Augusta,GA30912	58-1418202	501 c3	136,563	Basic Science
(27) Harvard University 1033 Massachusetts Ave Ste 3 Cambridge,MA02138	04-2103580	501 c3	218,232	Basic Science
(28) Johns Hopkins University 1101 E 33RD St Ste D200 Baltimore,MD21218	52-0595110	501 c3	109,250	Basic Science
(29) Joslin Diabetes Center One Joslin Place Boston,MA02215	04-2203836	501 c3	437,000	Basic Science
(30) Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 1124 West Carson Street Bldg N-16 Torrance,CA90502	95-2138184	501 c3	109,250	Basic Science
(31) Louisiana State University Health Sciences Center Shreveport 1501 Kings Highway Shreveport,LA71130	72-0702002	501 c3	109,250	Basic Science
(32) Marine Biological Laboratory 7 MBL Street Woods Hole,MA02543	04-2104690	501 c3	107,687	Basic Science
(33) Massachusetts General Hospital 50 Staniford Street 10th Floor Boston,MA02114	04-2697983	501 c3	109,250	Basic Science
(34) Mayo Clinic Rochester 200 First Street Southwest Rochester,MN55906	41-6011702	501 c3	109,250	Basic Science
(35) Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee,WI53226	39-0806261	501 c3	327,750	Basic Science
(36) Mount Sinai School of Medicine One Gustav L Levy Place Box 3500 New York,NY10029	13-6171197	501 c3	348,630	Basic Science
(37) Northwestern University 633 Clark Street Room 2-502 Evanston,IL60208	36-2167817	501 c3	109,250	Basic Science
(38) Pacific Northwest Research Institute 720 Broadway Seattle,WA98122	91-0667886	501 c3	109,250	Basic Science
(39) Palo Alto Institute for Research and Education 3801 Miranda Avenue Palo Alto,CA94304	77-0207331	501 c3	109,250	Basic Science
(40) Pennington Biomedical Research Center 6400 Perkins Road Baton Rouge,LA70808	72-6000848	501 c3	327,750	Basic Science
(41) Pennsylvania State University School of Medicine Office of the Controller MC-G230 PO Hershey,PA17033	24-6000376	501 c3	109,250	Basic Science
(42) Portland VA Research Foundation PO Box 69539 Portland,OR97239	94-3090170	501 c3	109,203	Basic Science
(43) Regents of the University of Minnesota 450 McNamara Alumni Center Minneapolis,MN55455	41-6007513	501 c3	109,250	Basic Science
(44) Rush University Medical Center 1700 West Van Buren Street Chicago,IL60612	36-2174823	501 c3	109,250	Basic Science
(45) Saint Louis University 3545 Lindell Boulevard Saint Louis,MO63103	43-0654872	501 c3	218,500	Basic Science
(46) Department of Allied Health Sciences University of Connecticut 263 Farmington Ave Farmington,CT06030	06-0772160	501 c1	109,250	Basic Science
(47) State University of New York at Buffalo 12 Capen Hall Buffalo,NY14260	16-1514621	501 c3	109,250	Basic Science
(48) Temple University School of Medicine PO Box 824242 Philadelphia,PA19182	23-1365971	501 c3	109,250	Basic Science
(49) The Burnham Institute for Medical Research 10901 North Torrey Pines Road La Jolla,CA92037	51-0197108	501 c3	109,250	Basic Science
(50) The Cleveland Clinic Foundation 9500 Euclid Avenue NO H-18 Cleveland,OH44195	91-2153073	501 c3	109,250	Basic Science
(51) The Jackson Laboratory 600 Main Street POBox 9741 Bar Harbor,ME04609	01-0211513	501 c3	109,250	Basic Science
(52) The Regents of the University of California Davis One Shields Avenue Davis,CA95616	94-6036494	501 c3	218,500	Basic Science
(53) The Regents of the University of California San Francisco 3333 California Street Ste 315 San Francisco,CA94143	94-6036493	501 c3	218,500	Basic Science
(54) The State University of New York Research Foundation 750 E Adams Street Syracuse,NY13210	14-1368361	501 c3	218,500	Basic Science
(55) The University of Arizona 888 N Euclid Ave Room 510 PO Box 33 Tucson,AZ85719	74-2652689	115	103,500	Basic Science
(56) The University of Tennessee Health Science Center 62 Dunlap Suite 300 Memphis,TN38163	62-6001636	501 c3	109,250	Basic Science
(57) The University of Texas at El Paso 500 West University Avenue El Paso,TX79968	74-6000813	170c1	109,250	Basic Science
(58) The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio,TX78229	74-1586031	170c1	109,250	Basic Science
(59) The University of Texas Medical Branch 301 University Boulevard Galveston,TX77555	74-6000949	170c1	109,250	Basic Science
(60) Thomas Jefferson University 201 South 11th Street Martin Buildi Philadelphia,PA19107	23-1352651	501 c3	109,250	Basic Science
(61) Trustees of the University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia,PA19104	23-1352685	501 c3	218,500	Basic Science
(62) University of Alabama at Birmingham 1530 3rd Ave South AB 990 Birmingham,AL35294	63-6005396	501 c3	327,750	Basic Science
(63) University of Cincinnati PO Box 210061 Cincinnati,OH45221	31-6000989	501 c3	109,250	Basic Science
(64) University of Colorado Denver PO Box 238 Denver,CO80291	84-6000555	501 c3	322,000	Basic Science
(65) University of Florida 302 Tigert Hall PO Box 113001 Gainesville,FL32610	59-6002052	501 c3	327,750	Basic Science
(66) University of Illinois at Chicago 809 S Marshfield Ave Chicago,IL60612	37-6000511	501 c3	218,500	Basic Science
(67) University of Iowa 4 Jessup Hall Room B5 Iowa City,IA52242	42-6004813	115	218,472	Basic Science
(68) University of Louisville Office of Controller Service Comple Louisville,KY40292	61-1029626	501 c3	218,500	Basic Science
(69) University of Massachusetts Medical School 55 Lake Avenue North Worcester,MA01655	04-3167352	115	319,845	Basic Science
(70) University of Medicine and Dentistry of New Jersey PO Box 2685 New Brunswick,NJ08903	22-1775306	501 c3	109,250	Basic Science
(71) University of Louisville Research Foundation Inc Office of Controller Service Comple Louisville,KY40292	23-7078461	501 c3	218,500	Basic Science
(72) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48109	38-6006309	501 c3	538,237	Basic Science
(73) University of Minnesota NW 5957 PO Box 1450 Minneapolis,MN55455	41-6007513	501 c3	109,131	Basic Science
(74) University of Nevada School of Medicine 401 W 2nd St Reno,NV89503	88-0387136	501 c3	109,250	Basic Science
(75) University of Oklahoma Health Sciences Center PO Box 26901 SCB228 Oklahoma City,OK73190	73-6017987	501 c3	218,500	Basic Science
(76) University of Pittsburgh 116 Atwood Street Suite 201 Pittsburg,PA15260	25-0965591	501 c3	518,938	Basic Science
(77) University of Rochester Medical Center 910 Genesee Street Brooks Landing B Rochester,NY14611	16-0743209	501 c3	109,250	Basic Science
(78) University of Southern California 1540 Alcazar Street CHP 100 Los Angeles,CA90033	95-1642394	501 c3	218,500	Basic Science
(79) University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas,TX75284	75-6002868	170c1	218,500	Basic Science
(80) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501 c3	218,500	Basic Science
(81) University of Vermont 340 Waterman Building Burlington,VT05405	03-0179440	501 c3	109,250	Basic Science
(82) University of Virginia PO Box 400195 Charlottesville,VA22904	54-6001796	501 c3	429,190	Basic Science
(83) University of Washington Gerberding Hall G80 Box 351202 Seattle,WA98195	91-6001537	115	109,250	Basic Science
(84) University of Wisconsin-Madison 21 N Park Street Suite 6401 Madison,WI53715	39-6006492	501 c3	109,250	Basic Science
(85) USDA ARS Western Human Nutrition Research Center 430 West Health Sciences Drive Davis,CA95616	72-0564834	115	105,450	Basic Science
(86) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	109,250	Basic Science
(87) Virginia Polytechnic Institute and State University 1880 Pratt Drive Suite 2006 Blacksburg,VA24060	54-6001805	501 c3	108,888	Basic Science
(88) Washington University in St Louis 700 Rose Dale Ave Box 1034 St Louis,MO63112	43-0653611	501 c3	27,313	Basic Science
(89) Wayne State University 5057 Woodward Avenue 13th floor Sui Detroit,MI48202	38-6028429	501 c3	109,250	Basic Science
(90) West Virginia University Research Corporation 886 Chestnut Ridge Road No 408 Morgantown,WV26506	55-0665758	501 c3	109,250	Basic Science
(91) Winthrop University Hospital 259 1st St Mineola,NY11501	11-1633486	501 c3	109,250	Basic Science
(92) Wright State University 3640 Colonel Glenn Hwy Dayton,OH45435	31-0732831	501 c3	109,250	Basic Science
(93) Yale University School of Medicine 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501 c3	437,000	Basic Science
(94) University of Southern California Keck School of Medicine 1975 Zonal Avenue KAM 300 Los Angeles,CA90089	95-1642394	501 c3	21,800	Bridging the Gaps BTG Award
(95) Beth Israel Deaconess Medical Center 330 Brookline Ave E BR-259 Boston,MA02219	04-2103881	501 c3	163,875	Career Development
(96) Children's Hospital Boston PO Box 41444 Boston,MA02241	04-2774441	501 c3	163,875	Career Development
(97) Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville,FL32224	59-3337028	501 c3	163,875	Career Development
(98) Scripps Research Institute 10550 N Torrey Pines Rd TPC-7 La Jolla,CA92037	33-0435954	501 c3	163,875	Career Development
(99) South Dakota Health Research Foundation 1100 E 21st St Suite 700 Sioux Falls,SD57105	46-0450378	501 c3	163,872	Career Development
(100) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48109	38-6006309	501 c3	351,500	Career Development
(101) University of Alabama at Birmingham 1530 3rd Ave South AB 990 Birmingham,AL35294	63-6005396	501 c3	187,625	Career Development
(102) University of Colorado Denver PO Box 238 Denver,CO80291	84-6000555	501 c3	492,053	Career Development
(103) University of Florida 302 Tigert Hall PO Box 113001 Gainesville,FL32610	59-6002052	501 c3	187,625	Career Development
(104) University of Kentucky Research Foundation 109 Kinkead Hall Lexington,KY40506	61-6033693	501 c3	163,875	Career Development
(105) University of Minnesota NW 5957 PO Box 1450 Minneapolis,MN55455	41-6007513	501 c3	163,875	Career Development
(106) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501 c3	28,500	Clinical Scholars
(107) Joslin Diabetes Center One Joslin Place Boston,MA02215	04-2203836	501 c3	28,500	Clinical Scholars
(108) Ohio State University Medical Center POBox 21781 Columbus,OH43221	31-1166607	501 c3	28,500	Clinical Scientist Training
(109) University of Illinois at Chicago 809 S Marshfield Ave Chicago,IL60612	37-6000511	501 c3	28,500	Clinical Scientist Training
(110) University of South Dakota 414 E Clark St Vermillion,SD57069	46-6000364	501 c3	28,500	Clinical Scientist Training
(111) Albert Einstein College of Medicine 1300 Morris Park Ave Bronx,NY10461	13-1624225	501 c3	379,989	Clinical/Translational Research
(112) Arizona State University PO Box 873503 Tempe,AZ85287	86-0196696	115	189,783	Clinical/Translational Research
(113) Baylor College of Medicine One Baylor Plaza Houston,TX77030	74-1613878	501 c3	190,000	Clinical/Translational Research
(114) Carl T Hayden Medical Research Foundation 650 E Indian School Road Phoenix,AZ85012	86-0907729	501 c3	190,000	Clinical/Translational Research
(115) Emory University School of Medicine 1599 Clifton Road NE 4th Floor MAIL Atlanta,GA30322	58-0566256	501 c3	190,000	Clinical/Translational Research
(116) Joslin Diabetes Center One Joslin Place Boston,MA02215	04-2203836	501 c3	379,725	Clinical/Translational Research
(117) Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 1124 West Carson Street Bldg N-16 Torrance,CA90502	95-2138184	501 c3	189,840	Clinical/Translational Research
(118) Massachusetts Eye and Ear Infirmary 23 Charles Street Boston,MA02114	04-2103591	501 c3	189,782	Clinical/Translational Research
(119) Massachusetts General Hospital 50 Staniford Street 10th Floor Boston,MA02214	04-2697983	501 c3	379,991	Clinical/Translational Research
(120) Mayo Clinic Rochester 200 First Street Southwest Rochester,MN55906	41-6011702	501 c3	91,343	Clinical/Translational Research
(121) Medical Technology and Practice Patterns Institute 4733 Bethesda Avenue Bethesda,MD20814	52-1483174	501 c3	93,620	Clinical/Translational Research
(122) MedStar Research Institute 108 Irving Street NW Washington,DC20010	52-6056274	501 c3	187,909	Clinical/Translational Research
(123) Ohio State University Medical Center POBox 21781 Columbus,OH43221	31-1166607	501 c3	190,000	Clinical/Translational Research
(124) Old Dominion University 5115 Hampton Boulevard Norfolk,VA23529	54-6052014	501 c3	190,000	Clinical/Translational Research
(125) Oregon Health & Science University 3181 SW Sam Jackson Park Rd L106 Ro Portland,OR97239	93-1176109	501 c3	181,138	Clinical/Translational Research
(126) Palo Alto Medical Foundation 2350 El Camino Real Mountain View,CA94040	94-1156581	501 c3	93,658	Clinical/Translational Research
(127) St Luke's Roosevelt Hospital Center Obesity Research Center 1111 Amsterdam Avenue New York,NY10025	13-2997301	501 c3	189,999	Clinical/Translational Research
(128) Stanford University School of Medicine 300 Pasteur Drive Stanford,CA94305	94-1156365	501 c3	190,000	Clinical/Translational Research
(129) State University of New York at Buffalo 12 Capen Hall Buffalo,NY14260	16-1514621	501 c3	189,972	Clinical/Translational Research
(130) Temple University School of Medicine PO Box 824242 Philadelphia,PA19182	23-1365971	501 c3	89,315	Clinical/Translational Research
(131) Texas A&M University System Health Science Center 400 Harvey Mitchell Parkway South College Station,TX77845	74-1238434	501 c3	94,592	Clinical/Translational Research
(132) The Cleveland Clinic Foundation 9500 Euclid Avenue NO H-18 Cleveland,OH44195	91-2153073	501 c3	71,280	Clinical/Translational Research
(133) The University of Chicago 1225 E 60th Street Chicago,IL60637	36-2177139	501 c3	190,000	Clinical/Translational Research
(134) The University of Tennessee Health Science Center 62 Dunlap Suite 300 Memphis,TN38163	62-6001636	501 c3	189,977	Clinical/Translational Research
(135) Torrey Pines Institute for Molecular Studies 11350 SW Village Parkway Port St Lucie,FL34987	33-0319501	501 c3	190,000	Clinical/Translational Research
(136) University of Alabama at Birmingham 1530 3rd Ave South AB 990 Birmingham,AL35294	63-6005396	501 c3	109,141	Clinical/Translational Research
(137) University of Colorado Denver PO Box 238 Denver,CO80291	84-6000555	501 c3	190,000	Clinical/Translational Research
(138) University of Maryland School of Medicine 620 W Lexington Street Baltimore,MD21201	52-6002033	115	190,000	Clinical/Translational Research
(139) University of Minnesota NW 5957 PO Box 1450 Minneapolis,MN55455	41-6007513	501 c3	380,000	Clinical/Translational Research
(140) University of Oklahoma Health Sciences Center PO Box 26901 SCB228 Oklahoma City,OK73190	73-6017987	501 c3	188,508	Clinical/Translational Research
(141) University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia,PA19104	23-1352685	501 c3	95,000	Clinical/Translational Research
(142) University of Pittsburgh 116 Atwood Street Suite 201 Pittsburg,PA15260	25-0965591	501 c3	186,514	Clinical/Translational Research
(143) University of South Carolina Research Foundation 915 Bull St Osborne Admininstration Columbia,SC29208	51-0517254	501 c3	121,287	Clinical/Translational Research
(144) University of Virginia PO Box 400195 Charlottesville,VA22904	54-6001796	501 c3	190,000	Clinical/Translational Research
(145) Washington University in St Louis 700 Rose Dale Ave Box 1034 St Louis,MO63112	43-0653611	501 c3	567,312	Clinical/Translational Research
(146) University of Minnesota NW 5957 PO Box 1450 Minneapolis,MN55455	41-6007513	501 c3	187,044	Distinguished Clinical Scientist
(147) Yale University School of Medicine 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501 c3	190,000	Distinguished Clinical Scientist
(148) Seattle Institute for Biomedical and Clinical Research 1660 South Columbian Way No S-151F Seattle,WA98122	91-0667886	501 c3	50,000	Henry Becton Innnovation
(149) Brigham and Women's Hospital 75 Francis Street Boston,MA02115	04-2312909	501 c3	47,500	Innovation
(150) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501 c3	47,500	Innovation
(151) Cedars-Sinai Medical Center 8700 Beverly Blvd W Hollywood,CA90048	95-1644600	501 c3	47,500	Innovation
(152) Eastern Virginia Medical School PO Box 1980 Norfolk,VA23501	54-6055378	501 c3	47,500	Innovation
(153) Florida State University 282 Champions Way A2201 Uca Tallahassee,FL32306	59-1961248	501 c3	47,500	Innovation
(154) Harvard University 1033 Massachusetts Ave Ste 3 Cambridge,MA02138	04-2103580	501 c3	47,500	Innovation
(155) Indiana University PO Box 500 Bloomington,IN47402	35-6018940	501 c3	47,500	Innovation
(156) Medical University of South Carolina 18 Bee Street Charleston,SC29425	57-6028985	501 c3	47,500	Innovation
(157) Schepens Eye Research Institute Harvard Medical School 20 Staniford Street Boston,MA02114	04-2129889	501 c3	47,500	Innovation
(158) The Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison,WI53715	39-6006492	170c1	47,500	Innovation
(159) The Regents of the University of California San Diego 9500 Gilman Drive 0954 La Jolla,CA92093	95-6006144	501 c3	43,820	Innovation
(160) Thomas Jefferson University 201 South 11th Street Martin Buildi Philadelphia,PA19107	23-1352651	501 c3	47,500	Innovation
(161) University of Florida 302 Tigert Hall PO Box 113001 Gainesville,FL32610	59-6002052	501 c3	47,500	Innovation
(162) University of Illinois at Chicago 809 S Marshfield Ave Chicago,IL60612	37-6000511	501 c3	47,500	Innovation
(163) University of Pittsburgh 116 Atwood Street Suite 201 Pittsburg,PA15260	25-0965591	501 c3	94,902	Innovation
(164) University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas,TX75284	75-6002868	170c1	47,497	Innovation
(165) University of Washington Gerberding Hall G80 Box 351202 Seattle,WA98195	91-6001537	115	45,000	Innovation
(166) University of Wisconsin-Madison 21 N Park Street Suite 6401 Madison,WI53715	39-6006492	501 c3	47,500	Innovation
(167) Children's Hospital Boston PO Box 41444 Boston,MA02115	04-2774441	501 c3	131,100	Junior Faculty
(168) Florida State University Research Foundation 2000 Levy Avenue Suite 351 Tallahassee,FL32310	59-3211153	501 c3	87,335	Junior Faculty
(169) Harvard University School of Public Health 677 Huntington Avenue Boston,MA02115	04-2103580	501 c3	131,100	Junior Faculty
(170) Oregon Health & Science University 3181 SW Sam Jackson Park Rd L106 Ro Portland,OR97239	93-1176109	501 c3	79,388	Junior Faculty
(171) University of Oklahoma Health Sciences Center PO Box 26901 SCB228 Oklahoma City,OK73190	73-6017987	501 c3	261,114	Junior Faculty
(172) Washington University in St Louis 700 Rose Dale Ave Box 1034 St Louis,MO63112	43-0653611	501 c3	131,100	Junior Faculty
(173) Weill Medical College of Cornell University 100 Broadway 8th Floor New York,NY10005	13-1623978	501 c3	131,100	Junior Faculty
(174) Albert Einstein College of Medicine 1300 Morris Park Ave Bronx,NY10461	13-1624225	501 c3	131,100	Junior Faculty
(175) Baylor College of Medicine One Baylor Plaza Houston,TX77030	74-1613878	501 c3	131,100	Junior Faculty
(176) Beth Israel Deaconess Medical Center 330 Brookline Ave E BR-259 Boston,MA02219	04-2103881	501 c3	130,388	Junior Faculty
(177) Boston University School of Medicine 715 Albany Street M-921 Boston,MA02118	04-2103547	501 c3	131,100	Junior Faculty
(178) Brigham and Women's Hospital 75 Francis Street Boston,MA02115	04-2312909	501 c3	131,100	Junior Faculty
(179) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH44106	34-1018992	501 c3	131,100	Junior Faculty
(180) Duke University 324 Blackwell St Washington Bldg Durham,NC27701	56-0532129	501 c3	131,100	Junior Faculty
(181) Eastern Virginia Medical School PO Box 1980 Norfolk,VA23501	54-6055378	501 c3	131,100	Junior Faculty
(182) Louisiana State University Health Sciences Center Shreveport 1501 Kings Highway Shreveport,LA71130	72-0702002	501 c3	131,100	Junior Faculty
(183) Mayo Clinic Arizona dba Mayo Clinic College of Medicine 13400 East Shea Blvd Scottsdale,AZ85259	86-0800150	501 c3	131,100	Junior Faculty
(184) Northwestern University 633 Clark Street Room 2-502 Evanston,IL60208	36-2167817	501 c3	124,196	Junior Faculty
(185) Texas A&M AgriLife Research 2147 TAMUS College Station,TX77843	74-6000541	501 c3	124,200	Junior Faculty
(186) Texas A&M University System Health Science Center 400 Harvey Mitchell Parkway South College Station,TX77845	74-1238434	501 c3	131,100	Junior Faculty
(187) The State University of New York Research Foundation 750 E Adams Street Syracuse,NY13210	14-1368361	501 c3	131,100	Junior Faculty
(188) The University of Kansas Medical Center 3901 Rainbow Blvd Kansas City,KS66160	23-7414917	501 c3	131,100	Junior Faculty
(189) The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio,TX78229	74-1586031	170c1	124,200	Junior Faculty
(190) Thomas Jefferson University 201 South 11th Street Martin Buildi Philadelphia,PA19107	23-1352651	501 c3	262,200	Junior Faculty
(191) Torrey Pines Institute for Molecular Studies 11350 SW Village Parkway Port St Lucie,FL34987	33-0319501	501 c3	131,100	Junior Faculty
(192) University of Colorado Denver PO Box 238 Denver,CO80291	84-6000555	501 c3	347,845	Junior Faculty
(193) University of Louisville Office of Controller Service Comple Louisville,KY40292	61-1029626	501 c3	124,200	Junior Faculty
(194) University of Miami PO Box 248106 Coral Gables,FL33124	59-0624458	501 c3	131,100	Junior Faculty
(195) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48109	38-6006309	501 c3	262,133	Junior Faculty
(196) University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia,PA19104	23-1352685	501 c3	131,100	Junior Faculty
(197) University of Pittsburgh 116 Atwood Street Suite 201 Pittsburg,PA15260	25-0965591	501 c3	130,986	Junior Faculty
(198) University of South Carolina Research Foundation 915 Bull St Osborne Admininstration Columbia,SC29208	51-0517254	501 c3	130,728	Junior Faculty
(199) University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas,TX75284	75-6002868	170c1	131,100	Junior Faculty
(200) University of Virginia School of Medicine PO Box 400195 Charlottesville,VA22904	54-6001796	501 c3	262,200	Junior Faculty
(201) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	131,100	Junior Faculty
(202) Wright State University 3640 Colonel Glenn Hwy Dayton,OH45435	31-0732831	501 c3	130,627	Junior Faculty
(203) Yale University School of Medicine 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501 c3	262,200	Junior Faculty
(204) Beckman Research Institute of the City of Hope 1450 East Duarte Road Duarte,CA91010	95-3432210	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(205) Indiana University School of Medicine PO Box 66057 Indianapolis,IN46266	35-6001673	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(206) The University of Chicago 1225 E 60th Street Chicago,IL60637	36-2177139	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(207) The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio,TX78229	74-1586031	170c1	42,750	Mentor-Based Minority Postdoctoral Fellowship
(208) University of California San Francisco 1855 Folsom St Suite 425 San Francisco,CA94143	94-6036493	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(209) University of Maryland Baltimore 620 W Lexington Street Baltimore,MD21201	52-6002033	115	10,688	Mentor-Based Minority Postdoctoral Fellowship
(210) University of Southern California Davis School of Gerontology 1540 Alcazar Street CHP 100 Los Angeles,CA90033	95-1642394	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(211) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(212) Washington University in St Louis 700 Rose Dale Ave Box 1034 St Louis,MO63112	43-0653611	501 c3	42,750	Mentor-Based Minority Postdoctoral Fellowship
(213) Albert Einstein College of Medicine 1300 Morris Park Ave Bronx,NY10461	13-1624225	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(214) Beth Israel Deaconess Medical Center 330 Brookline Ave E BR-259 Boston,MA02219	04-2103881	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(215) Boston Medical Center One Boston Medical Center Place Boston,MA02118	04-3314093	501 c3	21,375	Mentor-Based Postdoctoral Fellowship
(216) Brigham and Women's Hospital 45 Francis Street Boston,MA02115	04-2312909	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(217) Children's Hospital Boston PO Box 41444 Boston,MA02115	04-2774441	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(218) Columbia University POBox 29789 New York,NY10987	13-5598093	501 c3	150,000	Mentor-Based Postdoctoral Fellowship
(219) Dana-Farber Cancer Institute 450 Brookline Ave Boston,MA02215	04-2263040	501 c3	85,409	Mentor-Based Postdoctoral Fellowship
(220) Harvard University 1033 Massachusetts Ave Ste 3 Cambridge,MA02138	04-2103580	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(221) Harvard University School of Public Health 677 Huntington Avenue Boston,MA02115	04-2103580	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(222) Joslin Diabetes Center One Joslin Place Boston,MA02215	04-2203836	501 c3	213,750	Mentor-Based Postdoctoral Fellowship
(223) La Jolla Institute for Allergy and Immunology 9420 Athena Circle La Jolla,CA92037	33-0328688	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(224) Massachusetts General Hospital 50 Staniford Street 10th Floor Boston,MA02214	04-2697983	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(225) Mayo Clinic Rochester 200 First Street Southwest Rochester,MN55906	41-6011702	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(226) Pacific Northwest Research Institute 720 Broadway Seattle,WA98122	91-0667886	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(227) Salk Institute for Biological Studies 10010 N Torrey Pines Road San Diego,CA92037	95-2160097	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(228) Seattle Institute for Biomedical and Clinical Reseach 1660 South Columbian Way No S-151F Seattle,WA98108	91-1452438	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(229) Stanford University School of Medicine 300 Pasteur Drive Stanford,CA94305	94-1156365	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(230) The Broad Institute Inc 7 Cambridge Ctr Cambridge,MA02142	26-3428781	501 c3	21,375	Mentor-Based Postdoctoral Fellowship
(231) The J David Gladstone Institutes 1650 Owens St San Francisco,CA94158	23-7203666	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(232) The Regents of the University of California San Diego 9500 Gilman Drive 0954 La Jolla,CA92093	95-6006144	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(233) University of California San Francisco 3333 California Street Ste 315 San Francisco,CA94143	94-6036493	501 c3	128,250	Mentor-Based Postdoctoral Fellowship
(234) University of Colorado Denver PO Box 238 Denver,CO80291	84-6000555	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(235) University of Florida 302 Tigert Hall PO Box 113001 Gainesville,FL32610	59-6002052	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(236) University of Maryland School of Medicine 620 W Lexington Street Baltimore,MD21201	52-6002033	115	42,750	Mentor-Based Postdoctoral Fellowship
(237) University of Massachusetts Medical School 55 Lake Avenue North Worcester,MA01655	04-3167352	115	42,750	Mentor-Based Postdoctoral Fellowship
(238) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48109	38-6006309	501 c3	64,125	Mentor-Based Postdoctoral Fellowship
(239) University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia,PA19104	23-1352685	501 c3	128,250	Mentor-Based Postdoctoral Fellowship
(240) University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas,TX75284	75-6002868	170c1	169,015	Mentor-Based Postdoctoral Fellowship
(241) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(242) University of Washington Gerberding Hall G80 Box 351202 Seattle,WA98195	91-6001537	115	21,375	Mentor-Based Postdoctoral Fellowship
(243) University of Wisconsin-Madison 21 N Park Street Suite 6401 Madison,WI53715	39-6006492	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(244) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Crystal Ter Nashville,TN37203	62-0476822	501 c3	85,500	Mentor-Based Postdoctoral Fellowship
(245) Washington University in St Louis 700 Rose Dale Ave Box 1034 St Louis,MO63112	43-0653611	501 c3	128,250	Mentor-Based Postdoctoral Fellowship
(246) Weill Medical College of Cornell University 100 Broadway 8th Floor New York,NY10005	13-1623978	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(247) Whitehead Institute for Biomedical Research Nine Cambridge Center Cambridge,MA02142	06-1043412	501 c3	42,750	Mentor-Based Postdoctoral Fellowship
(248) Yale University School of Medicine 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501 c3	213,750	Mentor-Based Postdoctoral Fellowship

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image

133

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2012

Page 2

Part III

Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a)Type of grant or assistance	(b)Number of recipients	(c)Amount of cash grant	(f)Description of non-cash assistance
(1) Minority Undergraduate Internship	17	51,000	N/A
(2) Stipend-Student Loan Repayment	10	81,798	N/A

Part IV

Supplemental Information.

Complete this part to provide the information required in Part I, line 2, Part III, column (b), and any other additional information.

Identifier	Return Reference	Explanation
I	2	The American Diabetes Association Research Foundation closely monitors the use of grant funds. Each grantee is required to submit an Annual Progress Report, which includes a scientific and a financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the Annual Progress Report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. After the completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial portion, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future American Diabetes Association Research Foundation awards until the obligations for the award are complete.
III	1,2	The American Diabetes Association Research Foundation program provides support to undergraduate minority students and young scientists through Minority Undergraduate Internship and Junior Faculty Stipend Awards. The Minority Undergraduate Internship award funds the training of an underrepresented minority undergraduate student as they gain valuable experience in diabetes research through a one year internship. The American Diabetes Association Research Foundations Junior Faculty Stipend award is designed to support new faculty level investigators. The award supports individuals salary and research project through an annual loan repayment.

Schedule I (Form 990) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet

Attach to Form 990. SchJMediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all officers,
directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? .......

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? ................

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 5a or 5b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 6a or 6b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................

If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2012

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(1)Larry Hausner MBAChief Executive Officer	(i) (ii)	468,031	81,090	26,011	236,772	23,469	835,373	81,090
(2)Deborah L JohnsonChief Financial Officer	(i) (ii)	225,984		1,981	9,894	19,510	257,369
(3)Robert RatnerMDFACPFACE EFF572012Chief Scientific Medical Officer	(i) (ii)	259,570		3,231		942	263,743
(4)M Sue Kirkman MD EFF 112012-562012SVP, Medical Affairs Community Information	(i) (ii)	210,527	39,089	11,406	9,726	12,202	282,950

Schedule J (Form 990) 2012

Page 3

Part III

Supplemental Information

Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.

Identifier	Return Reference	Explanation
I	3	The Chief Executive Officer, the Chief Financial Officer, and Chief Scientific Medical Officer of the American Diabetes Association the Association also serve in these roles for the American Diabetes Association Research Foundation the Foundation. The Principal Officers of the Board of Directors of the Association use a Compensation Committee, compensation studies, and an independent consultant to establish the compensation of the Chief Executive Officer. The committee also reviews the compensation of the other officers to ensure compensation is appropriate based on industry benchmarks.
I	4b	The Chief Executive Officer is compensated by the American Diabetes Association and participates in its supplemental retirement plan. The reported retirement and other deferred compensation includes contributions to the Chief Executive Officers 457f plan in the amounts of 76,919 for an annual contribution and 58,385 for a long term incentive contribution.
II	3	Employment term for Dr. Robert Ratner, American Diabetes Association Chief Scientific Medical Officer, began on May 7, 2012.
II	4	Dr. M. Sue Kirkman, American Diabetes Association Senior Vice President Medical Affairs and Community Information, served the Research Foundation on an interim basis during the period 1/1/2012 5/6/2012.

Schedule J (Form 990) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

Schedule L
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Transactions with Interested Persons

Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V, line 38a or 40b.
MediumBullet

Attach to Form 990 or Form 990-EZ. MediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

Excess Benefit Transactions (section 501(c)(3) and section 501(c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.

1(a) Name of disqualified person	(c) Description of transaction	(d) Corrected?
1(a) Name of disqualified person	(c) Description of transaction	Yes	No

Enter the amount of tax incurred by organization managers or disqualified persons during the year under section 4958. ........................... Bullet Image

Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image

Part II

Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990-EZ, Part V, line 38a, or Form 990, Part IV, line 26; or if the organization reported an amount on Form 990, Part X, line 5, 6, or 22

(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	(d) Loan to or from the organization?		(e)Original principal amount	(f)Balance due	(g) In default?		(h) Approved by board or committee?		(i)Written agreement?
(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	To	From	(e)Original principal amount	(f)Balance due	Yes	No	Yes	No	Yes	No






Total ...... $

Part III

Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of assistance	(e) Purpose of assistance
(1) A Gordon Smith MD - University of U	Grant Review Committee Member	199,853	ADA-Ethicon Endo-Surgery/Covidien Research Award in Bariatric Surgery Diabetes
(2) A Wayne Orr PhD -Louisiana State Un	Grant Review Committee Member	131,100	Junior Faculty
(3) Abbas E Kitabchi PhD MD -The Univer	Grant Review Committee Member	189,977	Clinical/Translational Research
(4) Adolfo Garcia-Ocana PhD - Universit	Grant Review Committee Member	109,250	Basic Science
(5) Alan D Attie PhD - University of Wi	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(6) Alex F Chen MD PhD- University of P	Grant Review Committee Member	109,250	Basic Science
(7) Alyssa H Hasty PhD - Vanderbilt Uni	Grant Review Committee Member	42,750	Mentor-Based Minority Postdoctoral Fellowship
(8) Alyssa H Hasty PhD - Vanderbilt Uni	Grant Review Committee Member	150,000	ADA-Ethicon Endo-Surgery/Covidien Research Award in Bariatric Surgery Diabetes
(9) Anders H Berg MD PhD -Beth Israel D	Grant Review Committee Member	130,388	Junior Faculty
(10) Arun J Sharma PhD -Joslin Diabetes	Grant Review Committee Member	109,250	Basic Science
(11) Carlos Bernal-Mizrachi MD - Washing	Grant Review Committee Member	190,000	Clinical/Translational Research
(12) Chih-Hao Lee PhD - Harvard Universi	Grant Review Committee Member	109,250	Basic Science
(13) Chih-Pin Liu PhD- City of Hope Beck	Grant Review Committee Member	109,250	Basic Science
(14) Christian Vaisse MD PhD - Universit	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(15) Christian Vaisse MD PhD - Universit	Grant Review Committee Member	109,250	Basic Science
(16) Christian Vaisse MD PhD - Universit	Grant Review Committee Member	150,000	ADA-Novo Nordisk Award in Neurohormonal Control of Metabolism
(17) Christopher G Kevil PhD -Louisiana	Grant Review Committee Member	109,250	Basic Science
(18) Clayton E Mathews PhD -University o	Grant Review Committee Member	3,000	Minority Undergraduate Internship
(19) Clayton E Mathews PhD -University o	Grant Review Committee Member	109,250	Basic Science
(20) David A Bernlohr PhD - University o	Grant Review Committee Member	190,000	Clinical/Translational Research
(21) Dennis C Bruemmer MD PhD - Universi	Grant Review Committee Member	163,875	Career Development
(22) Domenico Accili MD -Columbia Univer	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(23) Donald K Scott PhD -Mount Sinai Sch	Grant Review Committee Member	109,250	Basic Science
(24) Dongmin Liu PhD - Virginia Polytech	Grant Review Committee Member	3,000	Minority Undergraduate Internship
(25) Dongmin Liu PhD - Virginia Polytech	Grant Review Committee Member	108,888	Basic Science
(26) Dongsheng Cai MD PhD - Albert Einst	Grant Review Committee Member	109,250	Basic Science
(27) Elizabeth Peters Blankenhorn PhD -D	Grant Review Committee Member	109,250	Basic Science
(28) Eva L Feldman MD PhD- University of	Grant Review Committee Member	109,250	Basic Science
(29) Frank B Hu MD PhD - Harvard Univers	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(30) Fumihiko Urano MD PhD - Washington	Grant Review Committee Member	93,656	Clinical/Translational Research
(31) George Gilbert Holz PhD - State Uni	Grant Review Committee Member	109,250	Basic Science
(32) Gerald Mark Reaven MD -Stanford Uni	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(33) Guillermo E Umpierrez MD -Emory Uni	Grant Review Committee Member	190,000	Clinical/Translational Research
(34) Hubert Ming Tse PhD - University of	Grant Review Committee Member	187,625	Career Development
(35) Ian R Sweet PhD-University of Washi	Grant Review Committee Member	45,000	Innovation
(36) Irene Elizabeth Schauer MD- Univers	Grant Review Committee Member	85,737	Clinical/Translational Research
(37) Jared Paul Rutter PhD- University o	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(38) Jeanine B Albu MD -St Luke's Roosev	Grant Review Committee Member	189,999	Clinical/Translational Research
(39) Jeffrey E Pessin PhD- Albert Einste	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(40) Jeffrey E Pessin PhD- Albert Einste	Grant Review Committee Member	109,250	Basic Science
(41) Jeonga Kim PhD- University of Alaba	Grant Review Committee Member	109,250	Basic Science
(42) Ji Li PhD- University at Buffalo Th	Grant Review Committee Member	109,250	Basic Science
(43) Joanna D Davies PhD -Torrey Pines I	Grant Review Committee Member	190,000	Clinical/Translational Research
(44) John Peter Mordes MD- University of	Grant Review Committee Member	107,896	Basic Science
(45) Jon D Piganelli PhD -University of	Grant Review Committee Member	109,250	Basic Science
(46) Jonathan S Bogan MD -Yale Universit	Grant Review Committee Member	109,250	Basic Science
(47) Judith G Regensteiner PhD- Universi	Grant Review Committee Member	190,000	Clinical/Translational Research
(48) Juraj Koska MD PhD - Carl T Hayden	Grant Review Committee Member	190,000	Clinical/Translational Research
(49) Kamal Rahmouni PhD - University of	Grant Review Committee Member	109,250	Basic Science
(50) Kristen Jane Nadeau MD -University	Grant Review Committee Member	187,625	Career Development
(51) Kyle Lee Hoehn PhD- University of V	Grant Review Committee Member	3,000	Minority Undergraduate Internship
(52) Kyle Lee Hoehn PhD- University of V	Grant Review Committee Member	131,100	Junior Faculty
(53) Leigh Perreault MD- University of C	Grant Review Committee Member	162,099	Career Development
(54) Lori Sussel PhD - Columbia Universi	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(55) Lu Cai MD PhD - University of Louis	Grant Review Committee Member	109,250	Basic Science
(56) Martin John Hessner PhD -Medical Co	Grant Review Committee Member	109,250	Basic Science
(57) Mary Elizabeth Patti MD -Joslin Dia	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(58) Mary Elizabeth Patti MD- Joslin Dia	Grant Review Committee Member	109,250	Basic Science
(59) Maureen Gannon PhD- Vanderbilt Univ	Grant Review Committee Member	45,000	ADA-Takeda Pharmaceuticals Beta Cell Award
(60) Meredith Ann Marguerite Hawkins MD	Grant Review Committee Member	65,806	ADA-Merck Clinical/Translational Postdoctoral Fellowship
(61) Michael A Harris PhD- Oregon Health	Grant Review Committee Member	181,138	Clinical/Translational Research
(62) Nader Sheibani PhD -University of W	Grant Review Committee Member	109,250	Basic Science
(63) Paolo Rinaudo PhD -University of Ca	Grant Review Committee Member	109,250	Basic Science
(64) Paresh Dandona MD PhD - University	Grant Review Committee Member	189,972	Clinical/Translational Research
(65) Philipp E Scherer PhD- University o	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(66) Preeti Kishore MD -Albert Einstein	Grant Review Committee Member	189,989	Clinical/Translational Research
(67) Qinglin Yang MD PhD - University of	Grant Review Committee Member	109,250	Basic Science
(68) Raghavendra G Mirmira MD PhD -India	Grant Review Committee Member	42,750	Mentor-Based Minority Postdoctoral Fellowship
(69) Rebecca Anne Simmons MD - Universit	Grant Review Committee Member	109,250	Basic Science
(70) Richard Glenn Kibbey MD PhD -Yale U	Grant Review Committee Member	109,250	Basic Science
(71) Rosario Scalia MD PhD -Temple Unive	Grant Review Committee Member	109,250	Basic Science
(72) Sean Harrison Adams PhD-USDA ARS We	Grant Review Committee Member	105,450	Basic Science
(73) Shannon Margaret Wallet PhD- Univer	Grant Review Committee Member	187,625	Career Development
(74) Tamas Laszlo Horvath DVM PhD -Yale	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(75) Thomas W Gettys PhD - Pennington Bi	Grant Review Committee Member	109,250	Basic Science
(76) Timothy E McGraw PhD- Weill Medical	Grant Review Committee Member	42,750	Mentor-Based Postdoctoral Fellowship
(77) Timothy J Lyons MD -University of O	Grant Review Committee Member	188,508	Clinical/Translational Research
(78) Xin-Liang Ma MD PhD -Thomas Jeffers	Grant Review Committee Member	109,250	Basic Science
(79) Yi-Guang Chen PhD-Medical College o	Grant Review Committee Member	109,250	Basic Science
(80) Young-Bum Kim PhD -Beth Israel Deac	Grant Review Committee Member	109,250	Basic Science
(81) Yu-Hua Tseng PhD -Joslin Diabetes C	Grant Review Committee Member	109,250	Basic Science
(82) Zhengping Yi PhD - Wayne State Univ	Grant Review Committee Member	3,000	Minority Undergraduate Internship
(83) Zhenqi Liu MD - University of Virgi	Grant Review Committee MemberGrant Review Committee MemberGrant Review Committee MemberGrant Review	190,000	Clinical/Translational Research

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50056A

Schedule L (Form 990 or 990-EZ) 2012

Page 2

Part IV

Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.

(a) Name of interested person	(c) Amount of transaction	(d) Description of transaction	(e) Sharing of organization's revenues?
(a) Name of interested person	(c) Amount of transaction	(d) Description of transaction	Yes	No

Part V

Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule L (see instructions).

Identifier	Return Reference	Explanation
III	1	The Scientific Review Panel follows the requirements of the American Diabetes Associations Conflict of Interest Policy when reviewing grant applications and providing funding recommendations. Members must recuse themselves for institutional, financial and personal conflicts of interest. Panel members are not permitted to participate in the grant review process if they are listed as the principal investigator of an application under consideration. In addition, members may not participate in the review of a specific grant if the principal investigator is a close collaborator or close associate of the panel member.

Schedule L (Form 990 or 990-EZ) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.

OMB No. 1545-0047

2012

Open to Public
Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Identifier	Return Reference	Explanation
		Form 990 Part I Line 1 Organizations mission/most significant activities The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research leading to the prevention and cure of diabetes, the prevention and cure of the complications of diabetes, and new therapies for individuals affected by diabetes. There are 26 million children and adults in the United States, or 8.3 of the population, who have diabetes. In addition, there are 79 million Americans who have pre-diabetes, a condition that occurs when a persons blood glucose levels are higher than normal but not high enough for a diagnosis of type 2 diabetes.
		Form 990 Part III Line 4 Research Fostering Innovation, Propelling Innovation, Powering Discovery -Throughout our history, we have been the leader in funding and supporting the research the world needs to stop the impact of diabetes. Weve funded nearly 4,000 projects and invested almost 640 million in diabetes research. In 2012, under the guidance and direction of the American Diabetes Association Research Foundation, Inc., we accelerated our commitment to research with the launch of Pathway to Stop Diabetes. This transformational program will inspire a new generation of scientists to apply their innovative thinking to the myriad issues of diabetes. Every hour, every day, someone, somewhere is working to move all of us closer to a cure. What unites diabetes researchers -- from graduate students to established scientists -- in the fight against diabetes A passion for their work. A desire to make a difference. And the American Diabetes Association. The Associations direct involvement in diabetes research extends back to the 1940s. Dr. Charles H. Best, one of four scientists credited with discovering insulin in the early 1920s, provided the Association with the framework and early leadership for a formalized program for diabetes research. And for more than half a century, the American Diabetes Association has been a world leader in supporting, funding, and honoring those who have dedicated themselves to diabetes research. The primary goals of the Associations Research Program are 1. Support the highest quality science across the broad spectrum of diabetes research. 2. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. 3. Support innovative research with a high potential to have a significant impact for patients with diabetes.
		Form 990 Part III Line 4 Continued.... To understand the impact and outcomes associated with our research funding, we initiated a comprehensive baseline program assessment of investigators. In 2012, our findings were published in Diabetes and Diabetes Care The average Association grant leads to more than six publications, providing the foundation for future advancements. Our funding expands the field by attracting and retaining diabetes researchers, with 98 of Association-supported scientists still focused on our cause. 85 of researchers received subsequent financial support for their work within five years of their award. A significant return on investments 56 million in grants invested in researchers in 2005 resulted in 421 million of subsequent allowance for those same investigators by 2011 a 7.5-fold increase. Types of Research Awards The American Diabetes Association Research Program supports basic and clinical/translational diabetes research aimed at preventing, treating and curing the disease. The diabetes research projects we support cover the spectrum from islet cell biology and transplantation techniques, to education and behavioral issues. Our core program offers investigator-initiated funding for basic science and clinical/translational research awards. Approximately 80 of Association-funded research falls under the Investigator-initiated Research Awards. Believing in the drive and potential of young and promising researchers, we also offer training awards to support scientists interested in diabetes research at various stages through their careers -- from medical school through assistant professorship. In fact, 98 of researchers supported by the Association continue their careers in diabetes research. In addition, the Association supports targeted and donor-driven research grants, funding specific program areas that are of interest to both the donor and the Association. The Career Development and Junior Faculty awards, for example, provide young scientists the salary and research support necessary to establish a track record of success that will allow them to receive increased funding opportunities from the National Institutes of Health NIH. Our mentor-based training awards match clinical students and recent doctoral candidates with outstanding senior scientists to help them strive towards careers in research. The Associations Research Program provides general grant support to both new and established investigators, specialized grants assisting clinical and innovative researchers, and opportunities for investigators as they advance their careers and the field of diabetes research and care.
		Form 990 Part III Line 4 Continued.... Headlines from projects supported by the American Diabetes Association Research Program in 2012 included Type 2 Diabetes Deteriorates Brain Function, January 2012. Innovative Immune Cell Re-education Technique Holds Promise for Type 1 Diabetes, February 2012. ADA Researcher Receives Top Award in Medicine, March 2012. Diabetes May Originate in the Intestines, April 2012. Identifying Type 2 Diabetes Risk in Obese Children, May 2012. Improving Cardiovascular Outcomes in Patients with Diabetes, June 2012. Accelerating Wound Closure in Patients with Diabetes, July 2012. Chemicals in Popular Consumer Products Associated with Increased Risk of Diabetes in Women, August 2012. Impact of Diet on Weight Loss High Protein vs. High Carbohydrate, September 2012. Novel Insight on Fat Cell Regulation May Hold Key for Anti-Obesity Drugs, October 2012. Association-Funded Researcher Honored with Prestigious Massachusetts Award, November 2012. Pathway to Stop Diabetes To accelerate the research needed to discover solutions and ultimately cure diabetes, the Association has launched a bold new initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. With a goal of funding 100 new diabetes researchers over the next decade, Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to new discoveries in diabetes prevention and treatment. In 2012, contributions to the campaign included 20 million from founding corporate sponsors and 800,000 from individuals for a total of 20.8 million. Grand totals for the campaign are now 27.2 million. Pathway to Stop Diabetes is in addition to ongoing Association research activities, and will significantly expand our research efforts by supporting innovative, basic, clinical, translation, epidemiological or health services research that is relevant to any type of diabetes, diabetes-related disease state of complication. Pathway will support creative scientists who are early in their career, or who are established but would like to expand their focus on diabetes research regardless of their current field of study. Through awards of 1.625 million over the course of five to seven years, the program will allow researchers to have the time and focus needed to explore new ideas.
		Form 990 Part VI Section A Line 1a The main responsibilities and focus of the Foundations Board is to advance, support, and promote charitable contributions by soliciting major gifts to fund the Research Program by making distribution of research awards and grants. The Board of Directors of the Foundation provides governance over the activities of the Foundation in accordance with the purposes, policies, and procedures of the American Diabetes Association. The Board delegates to the Foundation Executive Committee responsibility for management of the Foundation when the Board is not in session.
		Form 990 Part VI Section A Line 3,7a,7b The Foundations affairs are managed by the Foundations Board of Directors. The Board of Directors of the Foundations supervises, directs, and controls the activities of the Foundation in accordance with the mission, purposes, policies, and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibility for management of the Foundation when the Board is not in session. If a vacancy occurs among the Foundation officers for any reason, the Board of Directors of the American Diabetes Association shall fill such position for the unexpired portion of the term.
		Form 990 Part VI Section B Line 11a IRS Form 990 Review Process by the Governing Body The American Diabetes Association the Association conducts the responsibility to review and comment on the American Diabetes Association Research Foundation the Foundation draft IRS Form 990 through the Associations Audit Committee. The final and signed 990 was provided to the Associations Board of Directors prior to filing with the IRS. The form was made available to the Foundations Board of Directors after filing with the IRS.
		Form 990 Part VI Section B Line 12c Managing a Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, the Foundations Officers, Directors, and members of the Grant Review Panel must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in legal affairs manage the disclosure and monitoring processes of the Board. The senior staff on the Associations Scientific and Medical Division manage the disclosure and monitoring processes of the Grant Review Panel. Through review of the annual disclosures and review of the agendas of relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting.
		Form 990 Part VI Section B Line 12c Research Grants Review Committee Conflict of Interest with Research Grants Review Committee is managed through a written COI policy and acknowledged through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self-reported. The primary considerations addressed in the COI policy and program guidelines are outlined below - Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. - Financial Individuals are required to recuse themselves from reviewing grants that they stand to gain financially from if the grant were awarded co-PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review.
		Form 990 Part VI Section B Line 13 The American Diabetes Association has a written Whistleblower policy that applies to the Association and its subsidiary organizations.
		Form 990 Part VI Section B Line 14 The American Diabetes Association has a written Document Retention and Destruction policy that applies to the Association and its subsidiary organizations.
		Form 990 Part VI Section C Line 17 Filing Jurisdiction - Registration Number Alabama - AL97-256, Alaska - N/A, Arizona - 10145, Arkansas - N/A, California - CT81471, Colorado - 2002-3003670, Connecticut - 5084, District of Columbia - 981855, Florida - CH1618, Georgia - CH-001422, Hawaii - N/A, Illinois - CO 01-025537, Indiana - 000103829-000, Kansas - 177-257-3SO, Kentucky - 45, Louisiana - N/A, Maine - CO-1247, Maryland - 102, Massachusetts - O29317, Michigan - MICS 10326, Minnesota - N/A, Mississippi - 100000294, Missouri - CO-021-87, New Hampshire - 5006, New Jersey - CH-0581900, New Mexico - N/A, New York - 01/30/65, North Carolina - SL000618, North Dakota - 7894, Ohio - 01-0239, Oklahoma - N/A, Oregon - 16402, Pennsylvania - No. 21, Rhode Island - 95-233, South Carolina - 641, Tennessee - 5104, Utah - 6536093-Char, Virginia - N/A, Washington - 7664, West Virginia - N/A, Wisconsin -3020-800.
		Form 990 Part VI Section C Line 19 Document Disclosure The following documents are available on the American Diabetes Association website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, and Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, and Conflict of Interest Policy.
		Form 990 Part VII Section A The Chief Executive Officer, the Chief Financial Officer, and the Chief Scientific Medical Officer are compensated by the American Diabetes Association based on a standard average of 38 hours per week. The Associations Chief Scientific Medical Officer began employment on 5/7/2012. The Associations Senior Vice President Medical Affairs Community Information served the Research Foundation on an interim basis during the period 1/1/2012 5/6/2012.
		Form 990 Part XI Line 9 Other changes in net assets or fund balances of 1,006,675 reflect prior year Research Grant award refunds and forfeitures.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2012

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

- TIN:

SCHEDULE R
(Form 990)

Department of the Treasury
Internal Revenue Service

Related Organizations and Unrelated Partnerships

Complete if the organization answered "Yes" to Form 990, Part IV, line 33, 34, 35, 36, or 37.
MediumBullet

Attach to Form 990. MediumBullet

See separate instructions.

OMB No. 1545-0047

2012

Open to Public Inspection

Name of the organization

American Diabetes Association Research Foundation Inc

Employer identification number

54-1734511

Part I

Identification of Disregarded Entities (Complete if the organization answered "Yes" to Form 990, Part IV, line 33.)

(a) Name, address, and EIN (if applicable) of disregarded entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Total income	(e) End-of-year assets	(f) Direct controlling entity

Part II

Identification of Related Tax-Exempt Organizations (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1) American Diabetes Association 1701 N Beauregard Street Alexandria,VA22311 13-1623888	See Part VII	OH	501 c 3	7	N/A		No
(2) American Diabetes Association Property Titel Holding Corporation 1701 N Beauregard Street Alexandria,VA22311 54-1948004	See Part VII	VA	501 c 2	N/A	American Diabetes Association	Yes

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50135Y

Schedule R (Form 990) 2012

Page 2

Part III

Identification of Related Organizations Taxable as a Partnership (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Part IV

Identification of Related Organizations Taxable as a Corporation or Trust (Complete if the organization answered "Yes" to Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.)

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(i) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	Yes	No

Schedule R (Form 990) 2012

Page 3

Part V

Transactions With Related Organizations (Complete if the organization answered "Yes" to Form 990, Part IV, line 34, 35b, or 36.)

Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.

Yes

1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?

a Receipt of (i) interest (ii) annuities (iii) royalties or (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .

b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

f Dividends from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

g Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

h Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

i Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

j Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .

k Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .

l Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .

m Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .

Yes

n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .

Yes

o Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

p Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

q Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

r Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

s Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.

(a) Name of other organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) American Diabetes Association	c	30,202,315	Cash
(2) American Diabetes Association	m,n,o	1,216,401	FMV

Schedule R (Form 990) 2012

Page 4

Part VI

Unrelated Organizations Taxable as a Partnership (Complete if the organization answered "Yes" to Form 990, Part IV, line 37.)

Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code VUBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Schedule R (Form 990) 2012

Page 5

Part VII

Supplemental Information

Complete this part to provide additional information for responses to questions on Schedule R (see instructions).

Identifier	Return Reference	Explanation
II	1b	The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
II	2b	The mission of the American Diabetes Association Property Title Corporation is to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association.

Additional Data

Software ID:	12000057
Software Version:	12.11.306.3

1	Briefly describe the organization’s mission or most significant activities: The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research leading to the prevention and cure of diabetes. Please see complete mission statement in schedule O.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	16
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	16
5	Total number of individuals employed in calendar year 2011 (Part V, line 2a) ......	5	0
6	Total number of volunteers (estimate if necessary) .............	6	170
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 35,546,004 including grants of $ 35,546,004 ) (Revenue $ )
	Research See Schedule O

4b	(Code: ) (Expenses $ including grants of $ ) (Revenue $ )












4c	(Code: ) (Expenses $ including grants of $ ) (Revenue $ )












4d	Other program services (Describe in Schedule O.)
	(Expenses $ including grants of $ ) (Revenue $ )
4e	Total program service expenses35,546,004

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)............	1,326,920	312,515

(A) Name and business address	(B) Description of services	(C) Compensation
NA,




2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	34,135,315	55,590,601
9	Program service revenue (Part VIII, line 2g) .........		0
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	1,753	3,388
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)		0
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)...................	34,137,068	55,593,989
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	34,750,281	35,546,004
14	Benefits paid to or for members (Part IX, column (A), line 4).....		0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)		0
16a	Professional fundraising fees (Part IX, column (A), line 11e).....		0
b	Total fundraising expenses (Part IX, column (D), line 25) 760,251
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	729,850	1,216,401
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	35,480,131	36,762,405
19	Revenue less expenses. Subtract line 18 from line 12.......	-1,343,063	18,831,584
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	14,024,928	35,154,688
21	Total liabilities (Part X, line 26).............	8,975,876	10,265,209
22	Net assets or fund balances. Subtract line 21 from line 20.....	5,049,052	24,889,479

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)		(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(18) Deborah L Johnson........................................................................ Chief Financial Officer	3.00 .......................34.50	X	0	227,965	29,404
(19) Robert RatnerMDFACPFACE EFF572012........................................................................ Chief Scientific Medical Officer	2.00 .......................35.50	X	0	262,801	942
(20) M Sue Kirkman MD EFF 112012-562012........................................................................ SVP, Medical Affairs Community Information	2.00 .......................35.50	X	0	261,022	21,928

				(A) Total revenue	(B) Related or exempt function revenue	(C) Unrelated business revenue	(D) Revenue excluded from tax under sections 512, 513, or 514
1a	Federated campaigns..1a		5,703
b	Membership dues....1b
c	Fundraising events....1c
d	Related organizations...1d		33,202,315
e	Government grants (contributions)1e

f	All other contributions, gifts, grants, and similar amounts not included above1f		22,382,583

g	Noncash contributions included in lines 1a-1f:$
h	Total. Add lines 1a-1f.......			55,590,601
			Business Code
2a
b
c
d
e
f	All other program service revenue .
g	Total. Add lines 2a–2f........
3	Investment income (including dividends, interest, and other similar amounts).......			3,388			3,388
4	Income from investment of tax-exempt bond proceeds..
5	Royalties...........
		(i) Real	(ii) Personal
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)
d	Net rental income or (loss).......
		(i) Securities	(ii) Other
7a	Gross amount from sales of assets other than inventory
b	Less: cost or other basis and sales expenses
c	Gain or (loss)
d	Net gain or (loss)..........
8a	Gross income from fundraising events (not including $ of contributions reported on line 1c). See Part IV, line 18 ..
	a
b	Less: direct expenses ...b
c	Net income or (loss) from fundraising events..
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities...
10a	Gross sales of inventory, less returns and allowances .
	a
b	Less: cost of goods sold ..b
c	Net income or (loss) from sales of inventory..
Miscellaneous Revenue			Business Code
11a
b
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......
12	Total revenue. See Instructions......			55,593,989			3,388

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.		(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses
1	Grants and other assistance to governments and organizations in the United States. See Part IV, line 21	35,364,706	35,364,706
2	Grants and other assistance to individuals in the United States. See Part IV, line 22	132,798	132,798
3	Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16	48,500	48,500
4	Benefits paid to or for members	0
5	Compensation of current officers, directors, trustees, and key employees ....	0
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0
7	Other salaries and wages	0
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	0
9	Other employee benefits .......	0
10	Payroll taxes ...........	0
11	Fees for services (non-employees):
a	Management ......	1,216,401		456,150	760,251
b	Legal .........	0
c	Accounting ...........	0
d	Lobbying ...........	0
e	Professional fundraising services. See Part IV, line 17
f	Investment management fees ......	0
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........	0
12	Advertising and promotion ....	0
13	Office expenses .......	0
14	Information technology ......	0
15	Royalties ..	0
16	Occupancy ...........	0
17	Travel ............	0
18	Payments of travel or entertainment expenses for any federal, state, or local public officials ......	0
19	Conferences, conventions, and meetings ....	0
20	Interest ...........	0
21	Payments to affiliates .......	0
22	Depreciation, depletion, and amortization .....	0
23	Insurance ..............	0
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a
b
c
d
e	All other expenses	0
25	Total functional expenses. Add lines 1 through 24e	36,762,405	35,546,004	456,150	760,251
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).


			(A) Beginning of year		(B) End of year
1	Cashnon-interest-bearing .............			1
2	Savings and temporary cash investments .........		1,260,171	2	729,908
3	Pledges and grants receivable, net ...........		12,682,749	3	34,340,604
4	Accounts receivable, net .............			4
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
				5
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
				6
7	Notes and loans receivable, net .............			7
8	Inventories for sale or use ..............			8
9	Prepaid expenses and deferred charges ..........			9
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a
b	Less: accumulated depreciation .....	10b		10c
11	Investments—publicly traded securities ..........			11
12	Investments—other securities. See Part IV, line 11 .....		82,008	12	84,176
13	Investments—program-related. See Part IV, line 11 .....			13
14	Intangible assets ...............			14
15	Other assets. See Part IV, line 11 ...........			15
16	Total assets. Add lines 1 through 15 (must equal line 34)......		14,024,928	16	35,154,688
17	Accounts payable and accrued expenses .........			17
18	Grants payable .................		8,975,876	18	10,265,209
19	Deferred revenue ................			19
20	Tax-exempt bond liabilities .............			20
21	Escrow or custodial account liability. Complete Part IV of Schedule D..			21
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........			22
23	Secured mortgages and notes payable to unrelated third parties ..			23
24	Unsecured notes and loans payable to unrelated third parties ....			24
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................			25
26	Total liabilities. Add lines 17 through 25.........		8,975,876	26	10,265,209
	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............			27
28	Temporarily restricted net assets ...........		4,967,044	28	24,805,303
29	Permanently restricted net assets ...........		82,008	29	84,176
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........			30
31	Paid-in or capital surplus, or land, building or equipment fund .....			31
32	Retained earnings, endowment, accumulated income, or other funds			32
33	Total net assets or fund balances ...........		5,049,052	33	24,889,479
34	Total liabilities and net assets/fund balances ........		14,024,928	34	35,154,688

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If “Yes,”the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If “Yes,” the organizationmay be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................	Yes	No